UNSPSC 85612660: Bypass left hepatic duct to common bile duct with intraluminal device, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass left hepatic duct to common bile duct with intraluminal device, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0F164D9

UNSPSC 85612660 Bypass left hepatic duct to common bile duct with intraluminal device, percutaneous endoscopic approach is a Commodity code that does not reflect the actual work state and local governments are procuring under this classification. Recent state and local opportunities tagged to this code involve occupational medical surveillance, independent medical evaluations for disability retirement determinations, surgical benefit carve-out programs, specialty medical services for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which involve hepatic duct procedures or the specialized interventional medical device work the code nominally describes. The mismatch suggests either systematic miscoding in the state and local procurement systems submitting these opportunities or a fundamental data-quality issue in how this particular code has been applied.

The geographic spread of tagged opportunities spans Arizona (City of Phoenix), California (City of Long Beach, County of Santa Clara), Washington State (Washington State Department of Transportation), and Texas (Harris County), with no clear concentration in any single jurisdiction. The issuing bodies include city retirement offices, city health benefit programs, state transportation departments, county juvenile probation systems, county commissions, and county health systems—a broad mix of administrative functions unrelated to procedural cardiology or hepatobiliary surgery. Without opportunities that align to the code's actual clinical scope, the code shows no actionable recent activity for vendors specializing in hepatic bypass devices or related interventional supplies.